99mTc-HMPAO perfusion SPECT/CT in the diagnosis of brain death

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

This report describes a case of brain death (BD) evaluated by 99mTc-hexamethylpropylene amine oxime (HMPAO) single photon emission tomography/computed tomography (SPECT/CT). A 16-year-old boy with a history of rapid unexpected brain herniation due to pilocytic astrocytoma underwent 99mTc-HMPAO SPECT/CT for evaluation of brain death in the context of organ donation. Flow images demonstrated lack of blood flow to the brain, and delayed images showed absence of demonstrable radionuclide activity within the brain. SPECT/CT confirmed absence of tracer accumulation, and was deemed helpful for evaluation of the brain stem. 99mTc-HMPAO SPECT/CT is a valuable tool enabling imaging-based confirmation of BD.

Cite

CITATION STYLE

APA

Derlin, T., & Weiberg, D. (2016). 99mTc-HMPAO perfusion SPECT/CT in the diagnosis of brain death. Nuclear Medicine Review, 19, B22–B23. https://doi.org/10.5603/NMR.2016.0033

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free